(-)-11-hydroxy-δ8-THC-d3 (exempt preparation) (Synonyms: (-)-11-hydroxy-δ8-Tetrahydrocannabinol-d3,(-)-trans-δ8-THC-d3,7-hydroxy-δ6-THC-d3) |
Katalog-Nr.GC91736 |
(−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) is intended for use as an internal standard for the quantification of (−)-11-hydroxy-Δ8-THC by GC- or LC-MS.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: N/A
Sample solution is provided at 25 µL, 10mM.
(−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) is intended for use as an internal standard for the quantification of (−)-11-hydroxy-Δ8-THC by GC- or LC-MS. (−)-11-hydroxy-Δ8-THC is categorized as a phytocannabinoid metabolite.[1],[2] (–)-11-hydroxy-Δ8-THC is a metabolite of Δ8-THC . It has analgesic activity in mice. (–)-11-hydroxy-Δ8-THC-d3 is regulated as a Schedule I compound in the United States. (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
References:
[1].Watanabe, K., Yamamoto, I., Oguri, K., et al.Comparison in mice of pharmacological effects of Δ8-tetrahydrocannabinol and its metabolites oxidized at 11-positionEur. J. Pharm.63(1)1-6(1980).
[2].Rhee, M.H., Vogel, Z., Barg, J., et al.Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclaseJ. Med. Chem.40(20)3228-3233(1997).
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *